Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion type Assertion NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_head.
- NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion description "[Triggering via CD40 using NIH3T3 CD40 ligand transfectant (CD40LT) cells increased (> 30%) cell surface CD80, CD18, CD11a, CD11b, and CD11c expression on MM cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_provenance.
- NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion evidence source_evidence_literature NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_provenance.
- NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion SIO_000772 7535594 NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_provenance.
- NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion wasDerivedFrom befree-20150227 NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_provenance.
- NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_assertion wasGeneratedBy ECO_0000203 NP517425.RAUKdk5SzdRwNNFoPNbzBxCarqfDVN5E1l9LFg9fVtIRQ130_provenance.